Back to Results
First PageMeta Content
Patent infringement / Clinical research / Abbreviated New Drug Application / Prior art / Title 35 of the United States Code / Food and Drug Administration / Trademark / Law / Patent law / United States patent law / Pharmaceutical sciences


Microsoft Word - 8991638_1.docx
Add to Reading List

Document Date: 2015-03-30 01:53:08

Open Document

File Size: 53,58 KB

Share Result on Facebook

City

Washington / D.C. / Salt Lake City / Miami / New York / /

Company

M. Peterson FOLEY & LARDNER LLP / E. Hanna (#5494) FOLEY & LARDNER LLP / ARSHT & TUNNELL LLP / DELAWARE NOVEN PHARMACEUTICALS INC. / Defendant ALU / ACTAVIS LABORATORIES UT INC. / Plaintiff Noven Pharmaceuticals Inc. / Defendant Actavis Laboratories UT Inc. / /

Country

United States / /

/

Event

FDA Phase / /

Facility

LARDNER LLP Washington Harbour / /

IndustryTerm

generic pharmaceutical products / pharmaceutical product / generic product / manufacturing / pharmaceutical products / /

NaturalFeature

Delaware / /

Organization

United States Patent and Trademark Office / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE NOVEN PHARMACEUTICALS / United States Food and Drug Administration / /

Person

Steven J. Rizzi Ramy / Jack B. Blumenfeld / /

/

Position

COUNSEL / /

Product

Estradiol / Minivelle / Minivelle® / /

ProvinceOrState

Utah / Delaware / Florida / New York / /

SocialTag